MicroRNA-99 family members suppress homeobox A1 expression in epithelial cells

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Chen, Dan ^a,b   Chen, Zujian ^a,c   Jin, Yi ^a   Dragas, Dragan ^a   Zhang, Leitao ^a,d   Adjei, Barima S ^a   Wang, Anxun ^a,b   Dai, Yang ^e   Zhou, Xiaofeng ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b SUN YAT SEN UNIVERSITY   (China)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d SOUTHERN MEDICAL UNIVERSITY   (China)

^e University of Illinois at Chicago   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CTD SMALL PHOSPHATASE LIKE PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; MEMBRANE PROTEIN; MESSENGER RNA; MICRORNA; MICRORNA 99; PHOSPHATASE; PROTEIN BCL 2; PROTEIN N MYRISTOYLTRANSFERASE; PROTEIN N MYRISTOYLTRANSFERASE 1; SWI SNF RELATED MATRIX ASSOCIATED ACTIN DEPENDENT REGULATOR OF CHROMATIN SUBFAMILY A MEMBER 5; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HOXA1; TRANSMEMBRANE PROTEIN 30A; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIUM CELL; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; KERATINOCYTE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTO ONCOGENE;

CELL LINE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENOME-WIDE ASSOCIATION STUDY; HOMEODOMAIN PROTEINS; HUMANS; MICRORNAS; PROTO-ONCOGENE PROTEINS; TRANSCRIPTION FACTORS;

EID: 84891802037     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0080625     Document Type: Article

References (55)

1. Hertel J, Bartschat S, Wintsche A, Otto C, Of The Bioinformatics Computer Lab TS, et al. (2012) Evolution of the let-7 microRNA Family. RNA Biol 9: 231-241.
2. Heimberg AM, Sempere LF, Moy VN, Donoghue PC, Peterson KJ (2008) MicroRNAs and the advent of vertebrate morphological complexity. Proc Natl Acad Sci U S A 105: 2946-2950.
3. Christodoulou F, Raible F, Tomer R, Simakov O, Trachana K, et al. (2010) Ancient animal microRNAs and the evolution of tissue identity. Nature 463: 1084-1088.
4. Jin Y, Tymen SD, Chen D, Fang ZJ, Zhao Y, et al. (2013) MicroRNA-99 Family Targets AKT/mTOR Signaling Pathway in Dermal Wound Healing. PLoS One 8: e64434.
5. Chen Z, Jin Y, Yu D, Wang A, Mahjabeen I, et al. (2012) Down-regulation of the microRNA-99 family members in head and neck squamous cell carcinoma. Oral Oncol 48: 686-691.
6. Yin VP, Thomson JM, Thummel R, Hyde DR, Hammond SM, et al. (2008) Fgf-dependent depletion of microRNA-133 promotes appendage regeneration in zebrafish. Genes Dev 22: 728-733.
7. Sun D, Lee YS, Malhotra A, Kim HK, Matecic M, et al. (2011) miR-99 family of MicroRNAs suppresses the expression of prostate-specific antigen and prostate cancer cell proliferation. Cancer Res 71: 1313-1324.
8. Sun J, Chen Z, Tan X, Zhou F, Tan F, et al. (2013) MicroRNA-99a/100 promotes apoptosis by targeting mTOR in human esophageal squamous cell carcinoma. Med Oncol 30: 411.
9. Li BH, Zhou JS, Ye F, Cheng XD, Zhou CY, et al. (2011) Reduced miR-100 expression in cervical cancer and precursors and its carcinogenic effect through targeting PLK1 protein. Eur J Cancer 47: 2166-2174.
10. Wong TS, Liu XB, Wong BY, Ng RW, Yuen AP, et al. (2008) Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue. Clin Cancer Res 14: 2588-2592.
11. Nagaraja AK, Creighton CJ, Yu Z, Zhu H, Gunaratne PH, et al. (2010) A link between mir-100 and FRAP1/mTOR in clear cell ovarian cancer. Mol Endocrinol 24: 447-463.
12. Tovar V, Alsinet C, Villanueva A, Hoshida Y, Chiang DY, et al. (2010) IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockage. J Hepatol 52: 550-559.
13. Doghman M, El Wakil A, Cardinaud B, Thomas E, Wang J, et al. (2010) Regulation of insulin-like growth factor-mammalian target of rapamycin signaling by microRNA in childhood adrenocortical tumors. Cancer Res 70: 4666-4675.
14. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, et al. (1988) Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 106: 761-771.
15. Wreesmann VB, Wang D, Goberdhan A, Prasad M, Ngai I, et al. (2004) Genetic abnormalities associated with nodal metastasis in head and neck cancer. Head Neck 26: 10-15.
16. Vigneswaran N, Wu J, Zacharias W (2003) Upregulation of cystatin M during the progression of oropharyngeal squamous cell carcinoma from primary tumor to metastasis. Oral Oncol 39: 559-568.
17. Krause CJ, Carey TE, Ott RW, Hurbis C, McClatchey KD, et al. (1981) Human squamous cell carcinoma. Establishment and characterization of new permanent cell lines. Arch Otolaryngol 107: 703-710.
18. Rheinwald JG, Beckett MA (1981) Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultures from human squamous cell carcinomas. Cancer Research 41: 1657-1663.
19. Nakayama S, Sasaki A, Mese H, Alcalde RE, Matsumura T (1998) Establishment of high and low metastasis cell lines derived from a human tongue squamous cell carcinoma. Invasion Metastasis 18: 219-228.
20. Jiang L, Liu X, Kolokythas A, Yu J, Wang A, et al. (2010) Downregulation of the Rho GTPase signaling pathway is involved in the microRNA-138-mediated inhibition of cell migration and invasion in tongue squamous cell carcinoma. Int J Cancer 127: 505-512.
21. Liu X, Jiang L, Wang A, Yu J, Shi F, et al. (2009) MicroRNA-138 suppresses invasion and promotes apoptosis in head and neck squamous cell carcinoma cell lines. Cancer Lett 286: 217-222.
22. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, et al. (2003) Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 31: e15.
23. Henson BJ, Bhattacharjee S, O'Dee DM, Feingold E, Gollin SM (2009) Decreased expression of miR-125b and miR-100 in oral cancer cells contributes to malignancy. Genes Chromosomes Cancer 48: 569-582.
24. Gebeshuber CA, Martinez J (2012) miR-100 suppresses IGF2 and inhibits breast tumorigenesis by interfering with proliferation and survival signaling. Oncogene.
25. Dweep H, Sticht C, Pandey P, Gretz N (2011) miRWalk-database: prediction of possible miRNA binding sites by "walking" the genes of three genomes. J Biomed Inform 44: 839-847.
26. Kruger J, Rehmsmeier M (2006) RNAhybrid: microRNA target prediction easy, fast and flexible. Nucleic Acids Res 34: W451-454.
27. Jiang L, Liu X, Chen Z, Jin Y, Heidbreder CE, et al. (2010) MicroRNA-7 targets insulin-like growth factor 1 receptor (IGF1R) in tongue squamous cell carcinoma cells. Biochem J 432: 199-205.
28. Liu X, Wang C, Chen Z, Jin Y, Wang Y, et al. (2011) MicroRNA-138 suppresses epithelial-mesenchymal transition in squamous cell carcinoma cell lines. Biochem J 440: 23-31.
29. Jiang L, Liu X, Kolokythas A, Yu J, Wang A, et al. (2010) Down-regulation of the Rho GTPase signaling pathway is involved in the microRNA-138 mediated inhibition of cell migration and invasion in tongue squamous cell carcinoma. Int J Cancer 127: 505-512.
30. Jin Y, Chen Z, Liu X, Zhou X (2012) Evaluating the microRNA targeting sites by luciferase reporter gene assay. Methods Mol Biol 936: 117-127.
31. Jin Y, Wang C, Liu X, Mu W, Chen Z, et al. (2011) Molecular characterization of the microRNA-138-Fos-like antigen 1 (FOSL1) regulatory module in squamous cell carcinoma. J Biol Chem 286: 40104-40109.
32. Lerman G, Avivi C, Mardoukh C, Barzilai A, Tessone A, et al. (2011) MiRNA expression in psoriatic skin: reciprocal regulation of hsa-miR-99a and IGF-1R. PLoS One 6: e20916.
33. Dai Y, Zhou X (2010) Computational methods for the identification of microRNA targets. Open Access Bioinformatics 2: 29-39.
34. Mueller AC, Sun D, Dutta A (2013) The miR-99 family regulates the DNA damage response through its target SNF2H. Oncogene 32: 1164-1172.
35. Zheng YS, Zhang H, Zhang XJ, Feng DD, Luo XQ, et al. (2012) MiR-100 regulates cell differentiation and survival by targeting RBSP3, a phosphatase-like tumor suppressor in acute myeloid leukemia. Oncogene 31: 80-92.
36. Zhang X, Zhu T, Chen Y, Mertani HC, Lee KO, et al. (2003) Human growth hormone-regulated HOXA1 is a human mammary epithelial oncogene. J Biol Chem 278: 7580-7590.
37. Zhang X, Emerald BS, Mukhina S, Mohankumar KM, Kraemer A, et al. (2006) HOXA1 is required for E-cadherin-dependent anchorage-independent survival of human mammary carcinoma cells. J Biol Chem 281: 6471-6481.
38. Mohankumar KM, Xu XQ, Zhu T, Kannan N, Miller LD, et al. (2007) HOXA1-stimulated oncogenicity is mediated by selective upregulation of components of the p44/42 MAP kinase pathway in human mammary carcinoma cells. Oncogene 26: 3998-4008.
39. Mohankumar KM, Perry JK, Kannan N, Kohno K, Gluckman PD, et al. (2008) Transcriptional activation of signal transducer and activator of transcription (STAT) 3 and STAT5B partially mediate homeobox A1-stimulated oncogenic transformation of the immortalized human mammary epithelial cell. Endocrinology 149: 2219-2229.
40. Zha TZ, Hu BS, Yu HF, Tan YF, Zhang Y, et al. (2012) Overexpression of HOXA1 correlates with poor prognosis in patients with hepatocellular carcinoma. Tumour Biol 33: 2125-2134.
41. Ducker CE, Upson JJ, French KJ, Smith CD (2005) Two N- myristoyltransferase isozymes play unique roles in protein myristoylation, proliferation, and apoptosis. Mol Cancer Res 3: 463-476.
42. Perinpanayagam MA, Beauchamp E, Martin DD, Sim JY, Yap MC, et al. (2013) Regulation of co- and post-translational myristoylation of proteins during apoptosis: interplay of N-myristoyltransferases and caspases. FASEB J 27: 811-821.
43. Kato U, Inadome H, Yamamoto M, Emoto K, Kobayashi T, et al. (2013) Role for phospholipid flippase complex of ATP8A1 and CDC50A proteins in cell migration. J Biol Chem 288: 4922-4934.
44. Wellik DM (2007) Hox patterning of the vertebrate axial skeleton. Dev Dyn 236: 2454-2463.
45. Iimura T, Denans N, Pourquie O (2009) Establishment of Hox vertebral identities in the embryonic spine precursors. Curr Top Dev Biol 88: 201-234.
46. Alexander T, Nolte C, Krumlauf R (2009) Hox genes and segmentation of the hindbrain and axial skeleton. Annu Rev Cell Dev Biol 25: 431-456.
47. Kachgal S, Mace KA, Boudreau NJ (2012) The dual roles of homeobox genes in vascularization and wound healing. Cell Adh Migr 6: 457-470.
48. Ma L, Teruya-Feldstein J, Weinberg RA (2007) Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449: 682-688.
49. Yekta S, Shih IH, Bartel DP (2004) MicroRNA-directed cleavage of HOXB8 mRNA. Science 304: 594-596.
50. Weiss FU, Marques IJ, Woltering JM, Vlecken DH, Aghdassi A, et al. (2009) Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer. Gastroenterology 137: 2136-2145 e2131-2137.
51. Ohuchida K, Mizumoto K, Lin C, Yamaguchi H, Ohtsuka T, et al. (2012) MicroRNA-10a is overexpressed in human pancreatic cancer and involved in its invasiveness partially via suppression of the HOXA1 gene. Ann Surg Oncol 19: 2394-2402.
52. Hassan NM, Hamada J, Murai T, Seino A, Takahashi Y, et al. (2006) Aberrant expression of HOX genes in oral dysplasia and squamous cell carcinoma tissues. Oncol Res 16: 217-224.
53. Bitu CC, Destro MF, Carrera M, da Silva SD, Graner E, et al. (2012) HOXA1 is overexpressed in oral squamous cell carcinomas and its expression is correlated with poor prognosis. BMC Cancer 12: 146.
54. Zhu T, Starling-Emerald B, Zhang X, Lee KO, Gluckman PD, et al. (2005) Oncogenic transformation of human mammary epithelial cells by autocrine human growth hormone. Cancer Res 65: 317-324.
55. Delehedde M, Cho SH, Hamm R, Brisbay S, Ananthaswamy HN, et al. (2001) Impact of Bcl-2 and Ha-ras on keratinocytes in organotypic culture. J Invest Dermatol 116: 366-373.